glp-1 mitochondria JCI Multifaceted Roles of GLP-1 and

A patient must be assessed by an authorised prescriber a GP, endocrinologist, or telehealth doctor who evaluates their BMI, medical history, current medications, and weight-related comorbidities

Who May Benefit Most From Long Term Use People with obesity, type 2 diabetes, insulin resistance, metabolic syndrome, or cardiovascular disease often benefit most from long term GLP-1 therapy

A.MarmorS.HovertsenS.GronskiJ.et al (2021)

When manufacturing bottlenecks, high prices, and uneven insurance coverage restrict access through traditional channels, patients increasingly seek alternatives that are faster, cheaper, and more convenient

We're actively seeking early-stage founders innovating in GLP-1 treatment support with a focus on the following solutions: Tracking, Coaching & Companions: Personalized nutrition platforms that make healthy eating seamless and digital companions that integrate with the grocery shopping experience